지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
이용수
등록된 정보가 없습니다.
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
Long-chain Perfluoroalkyl Carboxylates(PFACs) activate Epithelial-Mesenchymal Transition(EMT) with inducing cytoskeleton abnormality in renal cell carcinoma(RCC) 3D cultures
환경독성보건학회 심포지엄 및 학술대회
2022 .10
Potassium Channelopathies and Gastrointestinal Ulceration
Gut and Liver
2016 .01
Protective Effects of Cinnamic Acid Derivatives on Gastric Lesion
Natural Product Sciences
2017 .12
Expression of survivin in squamous cell carcinoma and transitional cell carcinoma of the urinary bladder: A comparative immunohistochemical study
Investigative and Clinical Urology
2015 .01
The clinical management of hepatocellular carcinoma in China: Progress and challenges
Clinical and Molecular Hepatology
2023 .04
Clinicopathologic Significance of Survivin Expression in Relation to CD133 Expression in Surgically Resected Stage II or III Colorectal Cancer
Journal of Pathology and Translational Medicine
2017 .01
Hepatocellular Carcinoma Surveillance and Screening in NASH/NAFLD and Metabolic Syndrome Patients: Western vs. Korean Experiences
대한외과학회 학술대회 초록집
2021 .11
The emerging age-pattern changes of patients with hepatocellular carcinoma in Korea
Clinical and Molecular Hepatology
2023 .01
A novel strategy to promote liver regeneration: utilization of secretome obtained from survivin-overexpressing adipose-derived stem cells
Annals of Surgical Treatment and Research
2021 .12
Systemic therapy in advanced hepatocellular carcinoma
Clinical and Molecular Hepatology
2023 .04
The development of alcohol-associated hepatocellular carcinoma mouse model
한국실험동물학회 학술발표대회 논문집
2022 .07
How long should physicians follow up with patients after curative treatment for hepatocellular carcinoma?
Clinical and Molecular Hepatology
2020 .01
Toward user-friendly and evidence-based practice guidelines for hepatocellular carcinoma
Clinical and Molecular Hepatology
2023 .04
Phosphoinositide 3-kinase inhibitors are effective therapeutic drugs for the treatment of hepatocellular carcinoma?
Clinical and Molecular Hepatology
2020 .01
Surveillance for hepatocellular carcinoma: It is time to move forward
Clinical and Molecular Hepatology
2022 .10
Hepatocellular carcinoma statistics in South Korea
Clinical and Molecular Hepatology
2021 .01
What should be done to reduce the discrepancy between guidelines and real-life practice for hepatocellular carcinoma in Korea?
Clinical and Molecular Hepatology
2023 .04
Clinical practice guidelines and real-world practice for hepatocellular carcinoma in Taiwan: Bridging the gap
Clinical and Molecular Hepatology
2023 .04
Hepatocellular Carcinoma Arising from Hepatocellular Adenoma in an Elderly Male Patient
Journal of Liver Cancer
2021 .01
Tailored operations for Huge hepatocellular carcinoma
대한외과학회 학술대회 초록집
2019 .10
0